{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:15:30Z","timestamp":1791396930797,"version":"4.3.3"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01508","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T10:50:22Z","timestamp":1547031022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Contribution of Altered Endocannabinoid System to Overactive mTORC1 Signaling in Focal Cortical Dysplasia"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniel","family":"Garc\u00eda-Rinc\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"D\u00edaz-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Para\u00edso-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaira","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Aguareles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e1n","family":"de Salas-Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"de Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Mart\u00ednez-Cerde\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"P\u00e9rez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Galve-Roperh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1152\/jn.00164.2011","article-title":"Decreased hyperpolarization-activated currents in layer 5 pyramidal neurons enhances excitability in focal cortical dysplasia.","volume":"106","author":"Albertson","year":"2011","journal-title":"J. Neurophysiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainres.2012.06.009","article-title":"Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.","volume":"1470","author":"Arai","year":"2012","journal-title":"Brain Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1523\/JNEUROSCI.4134-09.2011","article-title":"Concerted action of CB1 cannabinoid receptor and deleted in colorectal cancer in axon guidance.","volume":"31","author":"Argaw","year":"2011","journal-title":"J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-007-0225-6","article-title":"Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly.","volume":"114","author":"Aronica","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13311-013-0251-0","article-title":"Epilepsy related to developmental tumors and malformations of cortical development.","volume":"11","author":"Aronica","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20211","article-title":"mTOR cascade activation distinguishes tubers from focal cortical dysplasia.","volume":"56","author":"Baybis","year":"2004","journal-title":"Ann. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"19115","DOI":"10.1073\/pnas.0509494102","article-title":"Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor.","volume":"102","author":"Berghuis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1126\/science.1137406","article-title":"Hardwiring the brain: endocannabinoids shape neuronal connectivity.","volume":"316","author":"Berghuis","year":"2007","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1523\/JNEUROSCI.3288-14.2015","article-title":"PKA-dependent phosphorylation of ribosomal protein S6 does not correlate with translation efficiency in striatonigral and striatopallidal medium-sized spiny neurons.","volume":"35","author":"Biever","year":"2015","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in huntington\u2019s disease.","volume":"134","author":"Bl\u00e1zquez","year":"2011","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1528-1167.2010.02777.x","article-title":"The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission.","volume":"52","author":"Bl\u00fcmcke","year":"2011","journal-title":"Epilepsia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nm.3127","article-title":"Targeting the endocannabinoid system in the treatment of fragile X syndrome.","volume":"19","author":"Busquets-Garcia","year":"2013","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"13693","DOI":"10.1073\/pnas.1514962112","article-title":"Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB 1 receptors on developing cortical neurons.","volume":"112","author":"de Salas-Quiroga","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.","volume":"15","author":"Devinsky","year":"2015","journal-title":"Lancet Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1016\/j.celrep.2017.11.106","article-title":"Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias.","volume":"21","author":"D\u2019Gama","year":"2017","journal-title":"Cell Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/cercor\/bhu039","article-title":"CB1 cannabinoid receptor-dependent activation of mTORC1\/Pax6 signaling drives Tbr2 expression and basal progenitor expansion in the developing mouse cortex.","volume":"25","author":"D\u00edaz-Alonso","year":"2015","journal-title":"Cereb. Cortex"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16651","DOI":"10.1523\/JNEUROSCI.0681-12.2012","article-title":"The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2\/Satb2 transcriptional regulation axis.","volume":"32","author":"D\u00edaz-Alonso","year":"2012","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1093\/cercor\/bhw309","article-title":"Loss of cannabinoid cb1receptors induces cortical migration malformations and increases seizure susceptibility.","volume":"27","author":"D\u00edaz-Alonso","year":"2017","journal-title":"Cereb. Cortex"},{"key":"B19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jneumeth.2014.07.009","article-title":"An organotypic brain slice preparation from adult patients with temporal lobe epilepsy.","volume":"235","author":"Eug\u00e8ne","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/brain\/awq385","article-title":"In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis.","volume":"134","author":"Goffin","year":"2011","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-010-0686-x","article-title":"The application of cortical layer markers in the evaluation of cortical dysplasias in epilepsy.","volume":"120","author":"Hadjivassiliou","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/EPI.13499","article-title":"Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.","volume":"7","author":"Hess","year":"2016","journal-title":"Epilepsia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.nbd.2018.02.013","article-title":"DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.","volume":"114","author":"Iffland","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev-pathol-052016-100138","article-title":"Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications.","volume":"12","author":"Iffland","year":"2017","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/brain\/awv045","article-title":"PI3K\/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.","volume":"138","author":"Jansen","year":"2015","journal-title":"Brain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nm.3824","article-title":"Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.","volume":"21","author":"Lim","year":"2015","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/ana.20949","article-title":"Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia.","volume":"60","author":"Ljungberg","year":"2006","journal-title":"Ann. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1523\/JNEUROSCI.4465-07.2008","article-title":"Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus.","volume":"28","author":"Lud\u00e1nyi","year":"2008","journal-title":"J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.neuron.2016.01.023","article-title":"Cannabinoid control of learning and memory through HCN Channels.","volume":"89","author":"Maroso","year":"2016","journal-title":"Neuron"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1046\/j.1460-9568.2003.02599.x","article-title":"Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain.","volume":"17","author":"Mato","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.ircmb.2015.07.006","article-title":"Ribosomal protein S6 phosphorylation.","volume":"320","author":"Meyuhas","year":"2015","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The Endocannabinoid system controls key epileptogenic circuits in the hippocampus.","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/bioinformatics\/btn241","article-title":"SNP analysis to results (SNPator): a web-based environment oriented to statistical genomics analyses upon SNP data.","volume":"24","author":"Morcillo-Suarez","year":"2008","journal-title":"Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1073\/pnas.0803545105","article-title":"Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning.","volume":"105","author":"Mulder","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nan.12462","article-title":"Review: the international consensus classification of focal cortical dysplasia - a critical update 2018.","volume":"44","author":"Najm","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/NEN.0b013e3181eac1f5","article-title":"Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias.","volume":"69","author":"Orlova","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nn.2369","article-title":"Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.","volume":"12","author":"Puighermanal","year":"2009","journal-title":"Nat. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.24547","article-title":"Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.","volume":"79","author":"Ricos","year":"2016","journal-title":"Ann. Neurol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187926","article-title":"Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans.","volume":"12","author":"Smith","year":"2017","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrn3937","article-title":"Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy.","volume":"16","author":"Soltesz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with lennox-gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0306-4522(03)00020-4","article-title":"Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain.","volume":"118","author":"Wang","year":"2003","journal-title":"Neuroscience"},{"key":"B43","doi-asserted-by":"publisher","first-page":"76415","DOI":"10.18632\/oncotarget.13001","article-title":"Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.","volume":"7","author":"Yao","year":"2016","journal-title":"Oncotarget"},{"key":"B44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroscience.2010.07.004","article-title":"CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.","volume":"170","author":"Zurolo","year":"2010","journal-title":"Neuroscience"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T10:50:25Z","timestamp":1547031025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":44,"alternative-id":["10.3389\/fphar.2018.01508"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01508","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"article-number":"1508"}}